---
accession : E-MEXP-2577
platform  : A-AFFY-143
pathway   : NFkB
cells     : CD14 positive monocyte derived macrophages
treatment : 10 ng/ml LPS
effect    : activating
hours     : 2

control   :
    - AB01
    - AB04
perturbed :
    - AB02
    - AB05

---
accession : E-MEXP-2577
platform  : A-AFFY-143
pathway   : NFkB
cells     : CD14 positive monocyte derived macrophages
treatment : 10 ng/ml LPS
effect    : activating
hours     : 6

control   :
    - AB01
    - AB04
perturbed :
    - AB03
    - AB06
...
